BofA/Merrill Lynch Upgrades Bristol-Myers Squibb Co. (BMY) to Buy
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $67.66 +1.11%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Neutral to Buy.
For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $32.15 yesterday.
For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $32.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMS presents five-year Camzyos data for heart condition at ESC
- Morgan Stanley Upgrades Coloplast A/S (COLOB:DC) (CLPBY) to Equalweight
- Evercore ISI Upgrades Deere (DE) to Outperform
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
